No abstract available
Keywords:
ACE2; COVID-19; SARS-CoV-2; TLR4; Toll-like receptor; angiotensin-converting enzyme 2; coronavirus; coronavirus disease 2019.
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angiotensin-Converting Enzyme 2 / metabolism*
-
Anti-Inflammatory Agents / pharmacology
-
Anti-Inflammatory Agents / therapeutic use
-
Antiviral Agents / pharmacology*
-
Antiviral Agents / therapeutic use
-
COVID-19 / metabolism
-
COVID-19 / virology
-
COVID-19 Drug Treatment*
-
Enzyme Activators / pharmacology
-
Enzyme Activators / therapeutic use
-
Humans
-
Inflammation / drug therapy
-
Inflammation / virology
-
Molecular Targeted Therapy
-
SARS-CoV-2 / drug effects
-
SARS-CoV-2 / isolation & purification
-
Sulfonamides / pharmacology
-
Sulfonamides / therapeutic use
-
Toll-Like Receptor 4 / antagonists & inhibitors*
-
Toll-Like Receptor 4 / metabolism
Substances
-
Anti-Inflammatory Agents
-
Antiviral Agents
-
Enzyme Activators
-
Sulfonamides
-
TLR4 protein, human
-
Toll-Like Receptor 4
-
ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2